Incidence of malignant disease by morphological type, in young persons aged 12–24 years in England, 1979–1997

  • J.M. Birch
    Corresponding author. Tel.: +44-161-727-2507/2509; fax: +44-161-727-2508
    Cancer Research UK, Paediatric & Familial Cancer Research Group, Royal Manchester Children's Hospital, Stancliffe, Hospital Road, Manchester M27 4HA, UK
    Search for articles by this author
  • R.D. Alston
    Cancer Research UK, Paediatric & Familial Cancer Research Group, Royal Manchester Children's Hospital, Stancliffe, Hospital Road, Manchester M27 4HA, UK
    Search for articles by this author
  • M. Quinn
    National Cancer Intelligence Centre, Office for National Statistics, 1 Drummond Gate, London SW1V 2QQ, UK
    Search for articles by this author
  • A.M. Kelsey
    Department of Diagnostic & Molecular Paediatric Pathology, Manchester Children's Hospital NHS Trust, Royal Manchester Children's Hospital, Hospital Road, Manchester M27 4HA, UK
    Search for articles by this author


      Cancer incidence data are generally presented in terms of primary site, but this method is inappropriate for cancers in young persons. We have used a morphology-based classification system to produce national incidence rates for cancers in persons aged 12–24 years by detailed diagnostic sub-type. The overall incidence rates for malignant disease in young persons aged 12–14, 15–19 and 20–24 years were 10.1, 14.4 and 22.6 per 100 000 population, respectively. The three most frequent cancer types in 12–14-year-olds were leukaemias, lymphomas and central nervous system (CNS) tumours. In 15–19-year-olds, lymphomas were most frequent and leukaemias second with carcinomas third. In 20–24-year-olds, lymphomas were again most frequent, but carcinomas and germ cell tumours were second and third. There was also variation with age in the ratios of rates in males and females. These changing incidence patterns have aetiological implications and provide clues for future hypothesis-based research.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Office for National Statistics, Cancer Statistics Registrations
        Registrations of Cancer Diagnosed in 1999, England. Series MB1 No. 30.
        Office for National Statistics, London2000
        • Office for National Statistics; Twentieth Century Mortality
        Mortality in England and Wales by Age, Sex, Year and Underlying Cause: Year 2000 Update.
        Office for National Statistics, London2002
        • World Health Organization
        World Cancer Report.
        in: Stewart B.W. Kleihues P. The Causes of Cancer. IARC Press, Lyon2003: 22-28 [chapter 2]
      1. Ablett S. Quest for Cure—the UK Children's Cancer Study Group: The First 25 Years. UKCCSG/Trident Communications. 2002
        • Bleyer W.A.
        Cancer in older adolescents and young adults.
        Med. Pediatr. Oncol. 2002; 38: 1-10
        • Birch J.M.
        • Alston R.D.
        • Kelsey A.M.
        • Quinn M.J.
        • Babb P.
        • McNally R.J.Q.
        Classification and incidence of cancers in adolescents and young adults in England 1979–1997.
        Br. J. Cancer. 2002; 87: 1267-1274
      2. Percy C. Van Holten V. Muir C. International Classification of Diseases for Oncology (ICD-O), 2nd edn. World Health Organization, Geneva1990
        • Quinn M.J.
        • Babb P.J.
        • Jones J.
        • Baker A.
        • Ault C.
        Cancer 1971–1997. Registrations of Cancer Cases and Deaths in England and Wales by Sex, Age, Year, Health Region and Type of Cancer [CD-ROM].
        Office for National Statistics, London1999
        • World Health Organization
        International Classification of Diseases for Oncology.
        1st edn. World Health Organization, Geneva1976
        • World Health Organization
        International Classification of Diseases, Injuries and Causes of Death, 9th revision.
        World Health Organization, Geneva1975
        • World Health Organization
        International Statistical Classification of Diseases and Related Health Problems, 10th revision.
        World Health Organization, Geneva1992
        • Francis B.
        • Green M.
        • Payne C.
        The GLIM System, Release 4 Manual.
        Clarendon Press, Oxford1993
        • Harris N.L.
        • Jaffe E.S.
        • Diebold J.
        • et al.
        The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, Nov. 1997.
        Ann Oncol. 1999; 10: 1419-1432
      3. Jaffe E.S. Harris N.L. Stein H. Vardiman J.W. The World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon2001
        • Lukes R.J.
        • Craver L.
        • Hall T.
        • Rappaport H.
        • Ruben P.
        Report of the nomenclature committee.
        Cancer Res. 1966; 26: 1311
        • Weiss S.W.
        • Goldblum J.R.
        Enzinger & Weiss's Soft Tissue Tumours.
        4th edn. Mosby, St. Louis2001
      4. Parkin C. Whelan S. Ferlay J. Raymond L. Young J. Cancer Incidence in Five Continents, Vol. VII. IARC Scientific Publications No. 143. IARC Press, Lyon1997
        • Birch J.M.
        • Marsden H.B.
        A classification scheme for childhood cancer.
        Int. J. Cancer. 1987; 40: 624-629
        • Kramárová E.
        • Stiller C.A.
        The international classification of childhood cancer, 1996.
        Int. J. Cancer. 1996; 68: 759-765
        • Smith M.A.
        • Gurney J.G.
        • Ries L.A.
        Cancer in adolescents 15–19 years old.
        in: Ries L.A. Smith M.A. Gurney J.G. Linet M. Tamra T. Young J.L. Bunin G. SEER Pediatric Monograph, United States SEER Program 1975–1997. NIH Pub. No. 99-4649. National Cancer Institute, Bethesda MD1999
        • Fritschi L.
        • Coates M.
        • McCredie M.
        Incidence of Cancer among New South Wales adolescents.
        Int. J. Cancer. 1995; 60: 355-360
        • Greaves M.F.
        Speculations on the cause of childhood acute lymphoblastic leukaemia.
        Leukaemia. 1998; 2: 120-125
        • Kinlen L.J.
        Epidemiological evidence for an infective basis in childhood leukaemia.
        Br. J. Cancer. 1995; 71: 1-5
        • Smith M.A.
        • Simon R.
        • Strickler H.D.
        • et al.
        Evidence that childhood acute lymphoblastic leukaemia is associated with an infectious agent linked to hygiene conditions.
        Cancer Causes and Control. 1998; 9: 285-298
        • Gale K.B.
        • Ford A.M.
        • Repp R.
        • et al.
        Backtracking leukaemia to birth.
        Proc. Natl. Acad. Sci. U.S.A. 1997; 94: 13950-13954
        • Wiemels J.L.
        • Cazzaniga G.
        • Daniotti M.
        • et al.
        Prenatal origin of acute lymphoblastic leukaemia in children.
        The Lancet. 1999; 354: 1499-1503
        • Birch J.M.
        • Alexander F.E.
        • Blair V.
        • Eden O.B.
        • Taylor G.M.
        • McNally R.J.Q.
        Space-time clustering patterns in childhood leukaemia support a role for infection.
        Br. J. Cancer. 2000; 82: 1571-1576
        • International Agency for Research on Cancer
        Human Immunodeficiency Viruses and Human T-Cell Lymphotropic Viruses, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 67.
        IARC Press, Lyon1996
        • Alexander F.E.
        • Patheal S.L.
        • Biondo A.
        • et al.
        Transplacental chemical exposure and risk of infant leukaemia with MLL gene fusion.
        Cancer Res. 2001; 61: 2542-2546
        • Baris D.
        • Zahm S.H.
        Epidemiology of lymphomas.
        Curr. Opin. Oncol. 2001; 12: 383-394
        • Glaser S.L.
        • Lin R.J.
        • Stewart S.L.
        • et al.
        Epstein-Barr virus-associated Hodgkin's disease.
        Int. J. Cancer. 1997; 70: 375-382
        • Flavell K.J.
        • Biddulph J.P.
        • Powell J.E.
        • et al.
        South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin's disease.
        Br. J. Cancer. 2001; 85: 350-356
        • Weggen S.
        • Bayer T.A.
        • von Deimling A.
        • et al.
        Low frequency of SV40, JC and BK polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas.
        Brain Pathol. 2000; 10: 85-92
        • Del Valle L.
        • Gordon J.
        • Assimakopoulou M.
        • et al.
        Detection of JC virus DNA sequences and expression of the viral regulatory protein T-antigen in tumors of the central nervous system.
        Cancer Res. 2001; 61: 4287-4293
        • Del Valle L.
        • Gordon J.
        • Enam S.
        • et al.
        Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma.
        J. Natl. Cancer Inst. 2002; 94: 267-273
        • McNally R.J.Q.
        • Cairns D.P.
        • Eden O.B.
        • Alexander F.E.
        • Kelsey A.M.
        • Birch J.M.
        An infectious aetiology for childhood brain tumours? Evidence from space-time clustering and seasonality analyses.
        Br. J. Cancer. 2002; 86: 1070-1077
        • McNally R.J.Q.
        • Kelsey A.M.
        • Cairns D.P.
        • Taylor G.M.
        • Eden O.B.
        • Birch J.M.
        Temporal increases in the incidence of childhood solid tumours seen in North West England [1954–1998] are likely to be real.
        Cancer. 2001; 92: 1967-1976
      5. Kleihues P. Cavenee W.K. World Health Organization, Pathology & Genetics of Tumours of the Nervous System. Chapter 14, Familial Tumour Syndromes Involving the Nervous System. IARC Press, Lyon2000, (215–242)
        • Li Y.-J.
        • Sanson M.
        • Hoang-Xuan K.
        • et al.
        Incidence of germ-line p53 mutations in patients with gliomas.
        Int. J. Cancer. 1995; 64: 383-387
        • Chen P.
        • Iavarone A.
        • Fick J.
        • Edwards M.
        • Prados M.
        • Israel M.A.
        Constitutional p53 mutations associated with brain tumors in young adults.
        Cancer Genet. Cytogenet. 1995; 82: 106-115
      6. Kleihues P. Cavenee W.K. World Health Organization, Pathology & Genetics of Tumours of the Nervous System. Chapter 1, Astrocytic Tumours. IARC Press, Lyon2000 (9-54)
        • Birch J.M.
        • Blair V.
        • Kelsey A.M.
        • et al.
        Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.
        Oncogene. 1998; 17: 1061-1068
        • Hamilton S.R.
        • Liu B.
        • Parsons R.E.
        • et al.
        The molecular basis of Turcot's syndrome.
        N. Engl. J. Med. 1995; 332: 839-847
        • Malkin D.
        • Chilton-MacNeill S.
        • Meister L.A.
        • Sexsmith E.
        • Diller L.
        • Garcea R.L.
        Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
        Oncogene. 2000; 20: 4441-4449
      7. Birch JM. The Li-Fraumeni syndrome and the role of the TP53 mutations in predisposition to cancer. In Eeles RA, Easton DF, Eng C, Ponder B, eds. Genetic Predisposition to Cancer. 2nd edn. London, Edward Arnold, [chapter 8] in press.

      8. Parkin D.M. Kramárová E. Draper G.J. International Incidence of Childhood Cancer, Vol. II. World Health Organisation, IARC Scientific Publications No. 144. IARC, Lyon1998
        • Lednicky J.A.
        • Stewart A.R.
        • Jenkins III, J.J.
        • Finegold M.J.
        • Butel J.S.
        SV40 DNA in human osteosarcomas shows sequence variation among T-antigen genes.
        Int. J. Cancer. 1997; 72: 791-800
        • Mendoza S.M.
        • Konishi T.
        • Miller C.W.
        Integration of SV40 in human osteosarcoma DNA.
        Oncogene. 1998; 17: 2457-2462
        • Carbone M.
        • Rizzo P.
        • Procopio A.
        • et al.
        SV40-like sequences in human bone tumors.
        Oncogene. 1996; 13: 527-535
        • Yamamoto H.
        • Nakayama T.
        • Murakami H.
        • et al.
        High incidence of SV40-like sequences detection in tumour and peripheral blood cells of Japanese osteosarcoma patients.
        Br. J. Cancer. 2000; 82: 1677-1681
        • McNally R.J.Q.
        • Kelsey A.M.
        • Eden O.B.
        • Alexander F.E.
        • Cairns D.P.
        • Birch J.M.
        Space-time clustering patterns in childhood solid tumours other than central nervous system tumours.
        Int. J. Cancer. 2003; 103: 253-258
      9. Quinn, M., Babb, P., Brock, A., Kirby, L., Jones, J. Cancer Trends in England and Wales 1950–1999. Studies on Medical & Population Subjects No. 66. London, office for National Statistics, 2001.

      10. Griffin B.E. Epstein-Barr virus (EBV) and human disease: facts, opinions and problems Mutat. Res.2000, 462, 395–405.

        • Lalloo F.
        • Varley J.
        • Ellis D.
        • et al.
        Prediction of pathogenic mutations in patients with early-onset breast cancer by family history.
        Lancet. 2003; 361: 1101-1102